G
GENIXUS
Critical thinking for critical care
About GENIXUS
Genixus operates in the healthcare sector, specializing in the manufacturing and supply of acute and critical care medicines. The company serves healthcare providers, including hospitals and clinics, by offering high-quality, transparent, and reliable pharmaceutical products. Genixus sets itself apart by adhering to stringent quality standards and ensuring total transparency throughout its supply chain. All components and ingredients are sourced from FDA and EMA licensed partners in the United States and Europe. The company employs state-of-the-art manufacturing processes, similar to those used in advanced biologic and vaccine production, to ensure the highest level of sterility and safety. Genixus generates revenue through the sale of its pharmaceutical products to healthcare institutions, focusing on improving patient care and safety. The market it operates in is highly regulated, requiring compliance with various healthcare standards and regulations. The business model revolves around delivering innovative solutions that allow healthcare providers to focus on patient care, thereby safeguarding and improving lives.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Kannapolis, United States
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 56.2/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Critical medical care, Pharmaceutical, Tech for Biotech and Pharma, Hard Tech, biomanufacturing
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jan 2022 | $20M | $80M | Undisclosed | — |
Growth signals
Latest recorded traffic for GENIXUS is 140 monthly website visits, down 22.2% over the last three months. GENIXUS's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about GENIXUS on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GENIXUS’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






